Rate control in atrial fibrillation

Isabelle C. Van Gelder*, Michiel Rienstra, Harry J. G. M. Crijns, Brian Olshansky

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

81 Citations (Web of Science)

Abstract

Control of the heart rate (rate control) is central to atrial fibrillation management, even for patients who ultimately require control of the rhythm. We review heart rate control in patients with atrial fibrillation, including the rationale for the intervention, patient selection, and the treatments available. The choice of rate control depends on the symptoms and clinical characteristics of the patient, but for all patients with atrial fibrillation, rate control is part of the management. Choice of drugs is patient-dependent. beta blockers, alone or in combination with digoxin, or non-dihydropyridine calcium-channel blockers (not in heart failure) effectively lower the heart rate. Digoxin is least effective, but a reasonable choice for physically inactive patients aged 80 years or older, in whom other treatments are ineffective or are contraindicated, and as an additional drug to other rate-controlling drugs, especially in heart failure when instituted cautiously. Atrioventricular node ablation with pacemaker insertion for rate control should be used as an approach of last resort but is also an option early in the management of patients with atrial fibrillation treated with cardiac resynchronisation therapy. However, catheter ablation of atrial fibrillation should be considered before atrioventricular node ablation. Although rate control is a top priority and one of the first management issues for all patients with atrial fibrillation, many issues remain.
Original languageEnglish
Pages (from-to)818-828
Number of pages11
JournalLancet
Volume388
Issue number10046
DOIs
Publication statusPublished - 20 Aug 2016

Cite this